There are 29.4 million people affected by obstructive sleep apnea (OSA) in the United States (AASM, 2016b). This disorder is classified as a chronic illness and is directly associated with a multitude of serious health sequelae. The risks for developing these sequelae increase if OSA is not diagnosed and treated (Badran, Ayas, and Laher, 2012). The American Association of Sleep Medicine (AASM) estimates 23.5 million people with OSA are undiagnosed, resulting in $149.6 billion in associated annual healthcare costs (AASM, 2016b). Among active duty military members the incidence of OSA may be as high as 50 (Wood, 2013).
Use of STOP-BANG Screening Questionnaire in Outpatient Setting: Increasing Both Identification of Obstructive Sleep Apnea Patients and Polysomnography Referral Accuracy
2017
77 pages
Report
Keine Angabe
Englisch